Ptc Therapeutics (PTCT) Research & Development (2012 - 2026)
Ptc Therapeutics' Research & Development was $99.15 million in Q2 2026, down 12.2% from $112.99 million a year earlier and down 1.7% from the prior quarter.
Ptc Therapeutics (PTCT) Research & Development (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ptc Therapeutics' Research & Development was $433.31 million through Jun 30, 2026, down 14.7% year-over-year; for FY2025, it was $455.25 million, down 14.8% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
- In earlier years, Research & Development was $534.48 million in FY2024 (-19.8%), $666.56 million in FY2023 (+2.3%), $651.5 million in FY2022 (+20.5%) and $540.68 million in FY2021 (+13.2%).
- The Q2 2026 figure marks the lowest quarterly Research & Development since Q3 2020.
- Compared with a year earlier, Research & Development was higher in two of the last eight quarters, with an average decline of 8.8%.
- The best year-over-year quarter for Research & Development over five years was Q3 2021 (growth of 40.7%); the worst was Q1 2024 (a decline of 40.5%).
- Per Business Quant data, PTCT's Research & Development in the three quarters before Q2 2026 was $100.87 million (Q1 2026), $133.13 million (Q4 2025) and $100.16 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Ptc Therapeutics | 5.50 Bn | -2.26 Bn | 340.60 Mn | 99.15 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.15 Mn |
| Mar 31, 2026 | 100.87 Mn |
| Dec 31, 2025 | 133.13 Mn |
| Sep 30, 2025 | 100.16 Mn |
| Jun 30, 2025 | 112.99 Mn |
| Mar 31, 2025 | 108.97 Mn |
| Dec 31, 2024 | 124.77 Mn |
| Sep 30, 2024 | 161.41 Mn |
| Jun 30, 2024 | 132.17 Mn |
| Mar 31, 2024 | 116.13 Mn |
| Dec 31, 2023 | 121.35 Mn |
| Sep 30, 2023 | 164.21 Mn |
| Jun 30, 2023 | 185.87 Mn |
| Mar 31, 2023 | 195.12 Mn |
| Dec 31, 2022 | 188.69 Mn |
| Sep 30, 2022 | 165.46 Mn |
| Jun 30, 2022 | 157.26 Mn |
| Mar 31, 2022 | 140.08 Mn |
| Dec 31, 2021 | 149.84 Mn |
| Sep 30, 2021 | 130.85 Mn |
Ptc Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PTCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PTCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PTCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();